Serial Number
85040521
Owner
ABRAXIS BIOSCIENCE, LLCAttorney
Camille M. MillerFiling Date
May 17, 2010
HISP 2.0 Trademark
Serial Number: 85040521
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
May 17, 2010
Registration Date
Not Registered
Published for Opposition
March 1, 2011
Goods & Services
computer software for use in the healthcare field for the integration of health data for patients, providers and payees, for research and development of next generation diagnostics and therapeutics tailored to specific molecular profiling of patient tissues and treatments for critical illnesses, for electronic data collection and data submission for developing, testing and validating next-generation diagnostics and pharmaceuticals to target pre-selected patients based on molecular profiles to predict drug response to particular therapeutics, for evaluating, analyzing and collecting data that integrates patient data, bioinformatics, discovery research, molecular medicine, and clinical developments in order to match patients with their personalized treatment regimens and preferred healthcare providers
Technology planning and consulting in the field of health care, namely, providing temporary use of software and hardware for the integration of health data for patients, providers and payees; design and development of hardware and software and computer networks solutions; research and development of next generation diagnostics and therapeutics tailored to specific molecular profiling of patient tissues and treatments for critical illnesses; electronic data collection and data submission services for developing, testing and validating next-generation diagnostics and pharmaceuticals to target pre-selected patients based on molecular profiles to predict drug response to particular therapeutics; computerized electronic data integration services, namely, providing a web site featuring temporary use of non-downloadable software and data automation and collection service using proprietary software to evaluate, analyze and collect service data that integrates patient data, bioinformatics, discovery research, molecular medicine, and clinical developments in order to match patients with their personalized treatment regimens and preferred healthcare providers; and to integrate health data from patients, providers and payees
